Dewpoint Therapeutics, Inc.

CIK 1828893 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dewpoint Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 13, 2026D/A0001828893-26-000001
Sep 23, 2025D0001828893-25-000002
Feb 4, 2022D0001567619-22-002514
Nov 2, 2020D0001567619-20-018534